PHAT Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PHAT shares is 198, representing 109.54% of the company's common stock.

GILDER GAGNON HOWE & CO LLC, in the last quarter, reduced its stake in PHAT by -30.07% restricting it's holding to 1.02 million shares of worth nearly $10.81M. WOODLINE PARTNERS LP also lessened -48.32% of the PHAT shares from its portfolio, reducing its holding to 566.44 thousand shares of worth $6.02M. NORTHERN TRUST CORP also shunned PHAT shares holding by -2.28% last quarter which brought its holding to 283.2 thousand shares worth $3.01M.

As per its latest 13F filing, UBS GROUP AG increased its stake in PHAT by 26.61% in the last quarter. The institutional holder raised its holding to 49.92 thousand shares having worth more than $530.18K. KLINGMAN & ASSOCIATES, LLC also added 100% more shares of PHAT to its portfolio, raising its holding to 10.38 thousand shares of worth $110.19K. MOORE CAPITAL MANAGEMENT, LP also increased its PHAT shares holding by 20% which brought its holding to 120 thousand shares worth $1.27M.

The insider with the most stakes in PHAT is N/A , N/A at the company. Additionally, PHAT stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own 7.7% percent of Phathom Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 2 transaction(s) in which PHAT insiders have sold stock, totaling 2.41K shares. Insiders that have sold shares include NABULSI AZMI, HENDERSON MOLLY, and CURRAN TERRIE.

There have been 2 transaction(s) during the past 6-months in which Phathom Pharmaceuticals, Inc. insiders have bought stock, totalling 22500 shares

Around 469.96K Phathom Pharmaceuticals, Inc. shares are held by insiders, which represents about 7.7% of PHAT stock.

PHAT N/A, N/A holds the largest portfolio of the company's shares. PHAT shares owned by N/A total nearly -.

UBS GROUP AG is the largest institutional owner in PHAT which holds 49.92 thousand shares worth $530.18K or 0.09% of the total PHAT shares outstanding followed by KLINGMAN & ASSOCIATES, LLC with ownership of 10.38 thousand shares representing 0.02% of the PHAT ownership. DAVENPORT & CO LLC is the third largest stakeholder with 10 thousand shares or 0.02% of the ownership worth more than $106.20K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PHAT is concerned, it is a stock which is optionable.

Number of PHAT shares short is 17.45M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 68.38M shares of PHAT are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PHAT has 55.75M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PHAT is 17.41.